Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 25% ± 8% | |
plasmacytoid dendritic cell | 6 studies | 25% ± 6% | |
astrocyte | 5 studies | 22% ± 7% | |
GABAergic neuron | 4 studies | 30% ± 12% | |
glutamatergic neuron | 4 studies | 37% ± 13% | |
microglial cell | 3 studies | 16% ± 1% | |
monocyte | 3 studies | 20% ± 1% | |
neuron | 3 studies | 21% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 25% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 1430.04 | 1802 / 1809 | 100% | 23.32 | 472 / 472 |
brain | 100% | 2172.47 | 2631 / 2642 | 100% | 13.79 | 705 / 705 |
thymus | 100% | 1632.59 | 652 / 653 | 100% | 8.92 | 603 / 605 |
kidney | 100% | 1693.94 | 89 / 89 | 99% | 11.47 | 896 / 901 |
adrenal gland | 100% | 1916.31 | 258 / 258 | 99% | 12.42 | 228 / 230 |
intestine | 100% | 1808.75 | 965 / 966 | 99% | 11.98 | 522 / 527 |
lung | 100% | 2109.03 | 577 / 578 | 99% | 8.82 | 1144 / 1155 |
breast | 100% | 1738.61 | 459 / 459 | 99% | 7.79 | 1103 / 1118 |
liver | 100% | 1298.31 | 225 / 226 | 99% | 7.46 | 402 / 406 |
ovary | 100% | 1754.58 | 180 / 180 | 98% | 10.08 | 423 / 430 |
bladder | 100% | 1920.33 | 21 / 21 | 98% | 9.38 | 495 / 504 |
prostate | 100% | 1862.27 | 245 / 245 | 98% | 5.86 | 493 / 502 |
stomach | 98% | 1016.84 | 353 / 359 | 100% | 13.37 | 285 / 286 |
uterus | 100% | 2580.85 | 170 / 170 | 97% | 9.11 | 443 / 459 |
esophagus | 97% | 1531.13 | 1404 / 1445 | 99% | 10.79 | 181 / 183 |
pancreas | 88% | 573.92 | 288 / 328 | 99% | 11.00 | 176 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 23.04 | 29 / 29 |
muscle | 100% | 1898.61 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3149.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.21 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.30 | 1 / 1 |
adipose | 100% | 1949.03 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1857.08 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 1403.57 | 859 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 5788.77 | 921 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 10.18 | 79 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010706 | Biological process | ganglioside biosynthetic process via lactosylceramide |
GO_0016266 | Biological process | O-glycan processing |
GO_0009312 | Biological process | oligosaccharide biosynthetic process |
GO_0009247 | Biological process | glycolipid biosynthetic process |
GO_0009101 | Biological process | glycoprotein biosynthetic process |
GO_0018146 | Biological process | keratan sulfate biosynthetic process |
GO_0097503 | Biological process | sialylation |
GO_1990743 | Biological process | protein sialylation |
GO_0019082 | Biological process | viral protein processing |
GO_0010707 | Biological process | globoside biosynthetic process via lactosylceramide |
GO_0030259 | Biological process | lipid glycosylation |
GO_0006688 | Biological process | glycosphingolipid biosynthetic process |
GO_0006486 | Biological process | protein glycosylation |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0008373 | Molecular function | sialyltransferase activity |
GO_0047288 | Molecular function | beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferase |
GO_0003836 | Molecular function | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity |
Gene name | ST3GAL2 |
Protein name | CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 (Alpha 2,3-ST 2) (Beta-galactoside alpha-2,3-sialyltransferase 2) (EC 2.4.3.4) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Monosialoganglioside sialyltransferase) (EC 2.4.3.2) (ST3Gal II) (ST3GalII) (ST3GalA.2) (Sialyltransferase 4B) (SIAT4-B) |
Synonyms | SIAT4B |
Description | FUNCTION: A beta-galactoside alpha2-3 sialyltransferase primarily involved in terminal sialylation of ganglio and globo series glycolipids . Catalyzes the transfer of sialic acid (N-acetyl-neuraminic acid; Neu5Ac) from the nucleotide sugar donor CMP-Neu5Ac onto acceptor Galbeta-(1->3)-GalNAc-terminated glycoconjugates through an alpha2-3 linkage . Sialylates GM1/GM1a, GA1/asialo-GM1 and GD1b gangliosides to form GD1a, GM1b and GT1b, respectively . Together with ST3GAL3, primarily responsible for biosynthesis of brain GD1a and GT1b that function as ligands for myelin-associated glycoprotein MAG on axons, regulating MAG expression and axonal myelin stability and regeneration (By similarity). Via GT1b regulates TLR2 signaling in spinal cord microglia in response to nerve injury (By similarity). Responsible for the sialylation of the pluripotent stem cell- and cancer stem cell-associated antigen SSEA3, forming SSEA4 . Sialylates with low efficiency asialofetuin, presumably onto O-glycosidically linked Galbeta-(1->3)-GalNAc-O-Ser . . |
Accessions | Q16842 ENST00000393640.8 ENST00000342907.3 |